# NIH Reporter #3U01AI198071-01S1

Strategy Trial of Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis

**Recipient:** University of Minnesota

**Award Amount:** $314,988.00
**Ceiling:** $314,988.00

**Awarded:** September 14, 2026

**Identifier:** 3U01AI198071-01S1

NIH-funded Phase II/III trial investigating individually customized immunotherapy for HIV-related cryptococcal meningitis.

### Description

Project to test personalized immunotherapy versus standard antifungal therapy for HIV-related cryptococcal meningitis, including assessment of cerebrospinal fluid inflammation.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11615077)